𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion)

✍ Scribed by Masamichi Wada; Tatsuya Iso; Bela F. Asztalos; Noriaki Takama; Tadashi Nakajima; Yukihiro Seta; Katsumi Kaneko; Yasuhiro Taniguchi; Hideo Kobayashi; Katsuyuki Nakajima; Ernst J. Schaefer; Masahiko Kurabayashi

Book ID
118422561
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
439 KB
Volume
207
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AAV gene therapy as a means to increase
AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency
✍ Stefan F. C. Vaessen; Robert Jan Veldman; Elisabeth M. Comijn; Jolanda Snapper; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

## Abstract ## Background Inherited apolipoprotein (Apo) A‐I deficiency is an orphan disorder characterized by high‐density lipoprotein (HDL)‐cholesterol deficiency and premature atherosclerosis. Constitutive over‐expression of ApoA‐I might provide a means to treat this disease. The present study

Evaluation of G-to-A substitution in the
Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency
✍ Harukuni Akita; Hitoshi Chiba; Masahiro Tsuji; Shu-Ping Hui; Yukihiro Takahashi; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 580 KB

The effect of a polymorphism, guanine (G) to adenine (A) substitution in the promoter of apolipoprotein A-I gene at a position 78 bp upstream of the transcription initiation site, on the serum high-density lipoprotein (HDL)-cholesterol level was studied in 168 Japanese subjects with HDL-cholesterol